CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Shares withheld for taxes Chief Accounting Officer gave up 2,108 shares (to pay taxes)
- 4 Open-market buy Director bought 1,867,912 shares at $3.25 ($6,070,714)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 798 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 797 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Interim Principal Exec Officer gave up 339 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 866 shares (to pay taxes)
- 4 Grant or award Director acquired 16,917 shares (grant or award)
- 4 Grant or award Director acquired 16,917 shares (grant or award)
- 4 Grant or award Director acquired 16,917 shares (grant or award)
- 4 Grant or award Director acquired 16,917 shares (grant or award)
- 4 Grant or award Director acquired 16,917 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 7,717,661 shares at $2.87 ($22,149,687)
- 4/A Grant or award Interim Principal Exec Officer acquired 15,734 shares (grant or award)
- 4/A Grant or award Chief Accounting Officer acquired 8,741 shares (grant or award)
- 4 Shares withheld for taxes Interim Principal Exec Officer gave up 1,549 shares (to pay taxes)
- 4 Open-market sale Chief Accounting Officer sold 2,954 shares at $14.78 ($43,660)
Page 7 of 39 · 776 filings